HCPCS Level IIdrugActive
J3247
Inj secukinumab intrav 1mg
BETOS: O1E
Effective: 2024-07-01
Referenced in 1 policies
Description
Injection, secukinumab, intravenous, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Cosentyx
Manufacturer
Novartis Pharmaceuticals Corporation
HCPCS Dosage
1 MG
Billing Units
125.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.